Welcome
Support Centre
13 May 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

Submit your study protocol
[ Print-friendly version ]
User participation in clinical assessment and intervention
ISRCTN ISRCTN90833792
ClinicalTrials.gov identifier
Public title User participation in clinical assessment and intervention
Scientific title The role of a Self-Assessment and INTervention package (SAINT) in improving general mental health outcomes and reducing depressive symptoms within an intellectual disability population
Acronym SAINT
Serial number at source N/A
Study hypothesis The primary hypothesis is that by providing a self-management assessment and intervention framework (SAINT), used in partnership by staff and service users there will be an improvement in general outcomes as described in the Health of the Nation Outcome Scales for people with Learning Disabilities (HoNOS-LD) and depressive symptoms as listed in the Beck Depression Inventory (BDI).
Ethics approval It is my intention to submit to ethics once I have the confirmation from Oxleas NHS Foundation Trust that they will participate. The invitation is currently being considered. The study will be submitted centrally and to Bromley Ethics Committee. Pending as of 25/01/2008.
Study design Randomised controlled trial (RCT)
Countries of recruitment United Kingdom
Disease/condition/study domain This study looks at self assessment and management of the individuals mental health particularly depression
Participants - inclusion criteria 1. Aged over 18, either sex
2. Mild intellectual disabilities as defined by an intelligence quotient [IQ] of between 50 - 70 (as measured by the Wechsler Adult Intelligence Scale - Revised [WAIS-R] and/or Wechsler Adult Intelligence Scale version three [WAIS-III]; a short IQ or WAIS will be performed where there is doubt)
3. Affective disorders in the Internation Classification of Diseases version 10 (ICD-10) section F30 - F39
4. Able to provide written consent
Participants - exclusion criteria 1. Service users suffering from head injury, post development
2. Service users with an IQ of under 50
3. Service users with an IQ of over 70
4. Service users who lack capacity
Anticipated start date 01/06/2008
Anticipated end date 01/06/2010
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 88
Interventions Both the experimental and control groups will receive treatment as usual that will include physical, psychological and social approaches. In the experimental group the SAINT self-management pack will be implemented. This involves self assessment and intervention from the service user with support where necessary. Due to the differing abilities this will be achieved with direction and support from the allocated nurse where appropriate.

The pack will be constructed following a delphi consultation which is designed to obtain consensus of expert and service user opinion.
Primary outcome measure(s) Increase in general mental health outcomes as defined within the HoNOS-LD, which has been specifically validated for use in intellectual disabilities populations. Roy et al (2002), reports that the HoNOS-LD is designed to monitor risk and vulnerability, and provides "a systematic summary of behaviours and functioning". It has 18 items graded for severity on a five point scale. The HoNOS-LD is specifically aimed at people with intellectual disability regardless of degree of impairment and who have co-existing mental health needs.

The BDI is a 21-item scale. The highest score on each of the questions is three, the highest possible total for the whole test is sixty-three. The lowest possible score for the whole test is zero.
Secondary outcome measure(s) Accuracy of service user self perception regarding risk and mental well being and its predictive validity will be examined via the self assessment and intervention logs. This data will be supplemented with an augmented Clinical Services Receipt Inventory to examine resource issues and quality of life questionnaires to examine what role support networks and standard of living might play in self intervention and management. The 'Quality of Life Scale' is a 40-item scale conducted by interview. The items are divided into four subscales:
1. Competence/productivity
2. Self-determination/independence
3. Satisfaction
4. Social belonging/integration in the community
Sources of funding Estia Centre (UK)
Trial website
Publications
Contact name Mr  Eddie  Chaplin
  Address 66 Snowsfields
Munro-Guys
  City/town London
  Zip/Postcode SE1 3SS
  Country United Kingdom
Sponsor Estia Centre (UK)
  Address c/o Prof. N Bouras
Munro-Guys
66 Snowsfields
  City/town London
  Zip/Postcode SE1 3SS
  Country United Kingdom
  Sponsor website: http://www.slam.nhs.uk/services/servicedetail.aspx?dir=6&id=751
Date applied 25/01/2008
Last edited 11/04/2008
Date ISRCTN assigned 11/04/2008
News
28 Sept 2007: 2007 Update of NHS Trusts Clinical Trials Register now available online
Aug 2007: Searches on ISRCTN register can now be bookmarked
Jul 2007: Patient information material field added to the ISRCTN Register
May 2007: WHO launches the International Clinical Trials Registry Search Portal
3 Apr 2007: Q&As regarding trial registration in the UK
4 Dec 2006: Trials taking place in the UK collated in 'Gateway'

© ISRCTN


BioMed Central